Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

76.63
-0.8700-1.12%
Volume:3.10M
Turnover:237.23M
Market Cap:237.65B
PE:34.06
High:76.97
Open:76.11
Low:76.11
Close:77.50
Loading ...

Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe

Zacks
·
03 Mar

Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire

TIPRANKS
·
02 Mar

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Business Wire
·
02 Mar

Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey
·
02 Mar

Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today

Zacks
·
01 Mar

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More

Zacks
·
28 Feb

Astrazeneca's Breast Cancer Drug Recommended for Approval in EU

MT Newswires Live
·
28 Feb

AstraZeneca, Daiichi Sankyo’s Enhertu recommended for approval in EU

TIPRANKS
·
28 Feb

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
28 Feb

Snowflake Expands Microsoft, OpenAI Partnership: Will Include Other Prominent Models Like Anthropic's Claude, Meta's Llama, And DeepSeek

Benzinga
·
27 Feb

AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright

TIPRANKS
·
27 Feb

AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds

Insider Monkey
·
27 Feb

AstraZeneca's Breast-Cancer Drug Results Seen as Positive Surprise -- Market Talk

Dow Jones
·
26 Feb

Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise

MT Newswires Live
·
26 Feb

AstraZeneca breast cancer drug shows positive results, shares up

Investing.com
·
26 Feb

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

Business Wire
·
26 Feb